Literature DB >> 12614219

Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia.

Xiaxin Li1, François Leteurtre, Vanderson Rocha, Philippe Guardiola, Roland Berger, Marie-Therese Daniel, Maria Helena Noguera, Odile Maarek, Gwenaëlle L E Roux, Pauline de la Salmonière, Patrice Richard, Eliane Gluckman.   

Abstract

Fanconi's anaemia (FA) is an autosomal recessive disorder characterized by progressive bone marrow failure and a susceptibility to cancer. Haematopoietic stem cell transplantation is the only curative method for restoring normal haematopoiesis, and survival is improved if the transplant is carried out before severe complications occur. However, the evolution of FA is difficult to predict because of the absence of known prognostic factors and the unknown function of the genes involved. In studying 71 FA patients, a correlation was found between severe aplastic anaemia (SAA) and the individual annual telomere-shortening rate (IATSR) in peripheral blood mononuclear cells (P < 10(-3)). Spontaneous apoptosis was highest in SAA patients or patients with high IATSR (> 200 bp/year) (P < 0.01, n = 18). Univariate and multivariate analyses showed that significant relative risks for evolution towards SAA were high IATSR (P < 10(-4)), and that a high number of chromosome breakages occurred in the presence of nitrogen mustard (P < 0.001). A high IATSR was also associated with an increased frequency of malignancy (P < 0.01). Thus, these biological parameters were related to the spontaneous evolution of FA and could be used as prognostic factors. These data indicated that telomeres might play a role in the evolution of bone marrow failure and malignant transformation in FA.

Entities:  

Mesh:

Year:  2003        PMID: 12614219     DOI: 10.1046/j.1365-2141.2003.04225.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.

Authors:  Rodrigo T Calado; William T Yewdell; Keisha L Wilkerson; Joshua A Regal; Sachiko Kajigaya; Constantine A Stratakis; Neal S Young
Journal:  Blood       Date:  2009-06-26       Impact factor: 22.113

Review 2.  Bone marrow failure and the telomeropathies.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Neal S Young
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 3.  Androgen Therapy for Acute Myeloid and Hairy Cell Leukemia.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2018-01-23

4.  FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.

Authors:  Xiaolei Pan; William C Drosopoulos; Louisa Sethi; Advaitha Madireddy; Carl L Schildkraut; Dong Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

5.  The Shwachman-Diamond SBDS protein localizes to the nucleolus.

Authors:  Karyn M Austin; Rebecca J Leary; Akiko Shimamura
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

Review 6.  The role of telomere biology in bone marrow failure and other disorders.

Authors:  Sharon A Savage; Blanche P Alter
Journal:  Mech Ageing Dev       Date:  2007-11-19       Impact factor: 5.432

Review 7.  Telomere maintenance and human bone marrow failure.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

Review 8.  Fanconi anemia proteins in telomere maintenance.

Authors:  Jaya Sarkar; Yie Liu
Journal:  DNA Repair (Amst)       Date:  2016-04-08

9.  Telomere length in inherited bone marrow failure syndromes.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Haematologica       Date:  2014-10-10       Impact factor: 9.941

10.  Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients.

Authors:  Ivana Joksic; Dragana Vujic; Marija Guc-Scekic; Andreja Leskovac; Sandra Petrovic; Maryam Ojani; Juan P Trujillo; Jordi Surralles; Maja Zivkovic; Aleksandra Stankovic; Predrag Slijepcevic; Gordana Joksic
Journal:  Genome Integr       Date:  2012-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.